Q-State Biosciences Announces Receipt of Fourth US National Institutes of Health SBIR Funding Award of 2022
CAMBRIDGE, MA, USA, September 19, 2022 /EINPresswire.com/ -- Q-State Biosciences (“Q-State”), a discovery technology and therapeutics company advancing programs for the treatment of serious central nervous system (CNS) disorders, announced today the …